Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-02-07
1991-01-29
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514250, 514242, 514247, 514254, 514269, 514273, 514272, 514274, 514287, 514284, 514285, 514279, 514291, 514292, 514293, A61K 31435, A61K 3147, A61K 3150, A61K 31505, C07D47114, C07D47122, C07D25306, C07D40314
Patent
active
049887050
ABSTRACT:
Novel polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives are disclosed which are useful for treating allergic reactions, inflammation, peptic ulcers, hypertension, and hyperproliferative skin diseases and for suppressing the immune response in mammals. Methods for preparing said compounds are also disclosed.
REFERENCES:
patent: 3931199 (1976-01-01), Nakanishi et al.
patent: 3931205 (1976-01-01), Nakanishi et al.
patent: 3947449 (1976-03-01), Durckheimer et al.
patent: 4596809 (1986-06-01), Sherlock
patent: 4680297 (1987-07-01), Blythin et al.
patent: 4680298 (1987-07-01), Blythin
patent: 4687774 (1987-08-01), Smith et al.
patent: 4760073 (1988-07-01), Blythin et al.
patent: 4801589 (1989-01-01), Smith et al.
patent: 4882332 (1989-11-01), Siegel et al.
Chem. Abstracts, 97(11):92173n (1982), p. 761.
Chem. Abstracts, 86(7):43594q (1977); p. 536.
Chem. Abstracts, 91(15):123609s (1979); p. 588.
Chem. Abstracts, 98:215861n (1983); p. 584.
Chem. Abstracts, 69:67264g (1968); 6280-6281.
D. J. Gale, Australian Journal of Chemistry, vol. 27, pp. 1295-1308 (1974).
Chem. Abstracts, 85(7):46621m (1976); p. 536.
Chem. Abstracts, 90(25):203821z (1979); p. 600-601.
Chem. Abstracts, 93(5):46364v (1980); p. 902.
Chem. Abstracts, 95(13):115339w (1981); p. 686.
Chem. Abstracts, 80(19):108503g (1974); p. 419.
Chem. Abstracts, 82(1):4230r (1976); pp. 367-368.
Chem. Abstracts, 88(19):130847j (1978); p. 32.
Chem. Abstracts, 93(19):186323f (1980); p. 863.
Chem. Abstracts, 88(3):22701y (1978); p. 617.
Chem. Abstracts, 87(17):127017n (1977); p. 28.
Chem. Abstracts, 84(9):59429j (1976); p. 522.
Chem Abstracts, 67(9):43655t (1967); 428-431.
Bernath et al., J. Heterocycl. Chem., 16(1), 137-144 (1979).
Chem. Abstracts, 88(13):89668m (1978); p. 522.
Chem. Abstracts, 85(3):21376x (1976); p. 695.
Chem. Abstracts, 74(15):74797q (1971); p. 303.
Chem. Abstracts, 91(5):32785e (1979); p. 33.
Fournier et al., Bulletin De La Societe Chimique De France, No. 1, pp. 364-369 (1968).
Derwent Abstract of Japanese published application 358144-391A.
Hawkins et al., Chem. Soc. Perkins Trans. I, 1983, pp. 2077-2087.
Chem. Ab., vol. 101: No. 38382t (1984).
Chem. Ab., vol. 96: No. 21782111k, p. 743 (1982).
Chem. Ab., vol. 85: No. 108567; p. 455 (1976).
Zh. Khim-Farm, 10 (5), pp. 18-22 (1976).
Chem. Ab., vol. 70: No. 77902y, pp. 348-349 (1969).
Liebigs Annalen der Chemie (1984), F. Eiden, pp. 1759-1777.
Zh. Obshch. Khim., 38(9)--pp. 2051-2064 (1968).
Friary Richard J.
Ganguly Ashit K.
Schwerdt John H.
Seidl Vera A.
Siegel Marvin I.
Lee Mary C.
Miller Stephen I.
Nelson James R.
Richter J.
Rosen Gerald S.
LandOfFree
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-814049